Director & Co-Chief Executive Officer
Director & Co-Chief Executive Officer at Guardant Health, Inc., filing insider transactions between 2025-06-05 and 2026-06-29.
| SEC ↗ |
| 2026-06-29 | GH | Sale | 25.8K | $150.53 | $3.9M | SEC ↗ |
| 2026-06-26 | GH | Sale | 52.9K | $151.16 | $8.0M | SEC ↗ |
| 2026-06-26 | GH | Sale | 64.0K | $150.49 | $9.6M | SEC ↗ |
| 2026-05-20 | GH | Sale | 21.2K | $106.99 | $2.3M | SEC ↗ |
| 2026-05-20 | GH | Sale | 1,366 | $103.82 | $142K | SEC ↗ |
| 2026-05-20 | GH | Sale | 200 | $100.95 | $20K | SEC ↗ |
| 2026-05-20 | GH | Sale | 26.4K | $112.76 | $3.0M | SEC ↗ |
| 2026-05-20 | GH | Sale | 28.9K | $110.10 | $3.2M | SEC ↗ |
| 2026-05-20 | GH | Sale | 33.1K | $108.11 | $3.6M | SEC ↗ |
| 2026-05-20 | GH | Sale | 37.2K | $111.14 | $4.1M | SEC ↗ |
| 2026-05-20 | GH | Sale | 37.9K | $112.02 | $4.2M | SEC ↗ |
| 2026-05-20 | GH | Sale | 900 | $102.57 | $92K | SEC ↗ |
| 2026-05-20 | GH | Sale | 9,852 | $108.97 | $1.1M | SEC ↗ |
| 2026-05-20 | GH | Sale | 11.9K | $105.01 | $1.3M | SEC ↗ |
| 2026-05-20 | GH | Sale | 1,200 | $105.88 | $127K | SEC ↗ |
| 2026-05-12 | GH | Sale | 50.0K | $100.32 | $5.0M | SEC ↗ |
| 2025-12-08 | GH | Sale | 15.0K | $104.21 | $1.6M | SEC ↗ |
| 2025-12-08 | GH | Sale | 4,240 | $106.00 | $449K | SEC ↗ |
| 2025-12-08 | GH | Sale | 30.8K | $105.34 | $3.2M | SEC ↗ |
| 2025-07-01 | GH | Sale | 27.9K | $51.40 | $1.4M | SEC ↗ |
| 2025-07-01 | GH | Sale | 72.1K | $50.67 | $3.7M | SEC ↗ |
| 2025-06-09 | GH | Sale | 77.9K | $50.09 | $3.9M | SEC ↗ |
| 2025-06-06 | GH | Sale | 39.8K | $50.07 | $2.0M | SEC ↗ |
| 2025-06-05 | GH | Sale | 1,680 | $50.00 | $84K | SEC ↗ |